Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The salivary film and residual saliva represent the physiological liquid environment of the oral cavity, serving as a critical interface for oral health and function (Humphrey & Williamson, 2001). The salivary film is a thin layer, approximately 70 to 100 micrometers thick, that coats the oral mucosa and teeth, while residual saliva is the volume of fluid remaining in the mouth after swallowing, typically ranging from 0.5 to 1.0 milliliters (Dawes, 2008). This system is not a discrete molecular target like a receptor or enzyme; rather, it is a complex biological matrix composed of water, electrolytes, and proteins such as mucins and lysozyme that provide lubrication, buffering, and antimicrobial protection (Nieuw Amerongen et al., 2007). In conditions like xerostomia or Sjogren's syndrome, the reduction or alteration of this film leads to significant morbidity, including dental caries and oral infections (NIH, 2023). Drugs such as pilocarpine and cevimeline target the production of this fluid by acting as cholinergic agonists, while various saliva substitutes are designed to physically replenish the film to alleviate symptoms (StatPearls, 2023). Understanding the dynamics of the salivary film is also vital for optimizing transmucosal drug delivery, as the film's thickness and turnover rate directly influence drug dissolution and absorption (Journal of Controlled Release, 2011).
Pharmacological agents interact with this system by either stimulating the autonomic nervous system to increase endogenous secretion or by providing exogenous polymers that mimic the viscoelastic and lubricating properties of the natural salivary film.
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Salivary film and residual saliva.